The Academy of Pharmaceutical Sciences

Mylan Announces Pricing of $1.15B in Senior Notes; Refinancing...

Mylan today announced the pricing of a private placement of $500 million aggregate principal amount of 1.80% Senior Notes due 2016 at an issue price of 99.925% and $650 million aggregate principal amount of 2.60% Senior Notes due 2018 at an issue price of 99.791%.

Motley Fool: What companies are doing right?

Q: Where can I learn about which companies are doing right by their employees, their communities, the environment and so on? - L.D. , Houston A: Check out the "Best Corporate Citizens" by CR Magazine, which focuses on corporate responsibility.

Latest AstraZeneca trial flops

The company had joined forces with rival Bristol-Myers Squibb to research a treatment for type 2 diabetes.

Teva Pharmaceutical Industries Ltd Now Covered by Maxim Group

The firm set a "buy" rating and a $56.00 price target on the stock. Maxim Group's target price points to a potential upside of 41.27% from the stock's previous close.

Teva Acquires MicroDose Therapeutx

Teva Pharmaceutical Industries Ltd. today announced that it has entered into a definitive agreement to acquire MicroDose Therapeutx, a pharmaceutical and drug delivery company focused on inhalation technologies and products for lung diseases and infections.

NIH to fund collaborations with industry to identify new uses for existing compounds

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.

New Market Study Published: CellCentric Ltd. - Pharmaceuticals &...

The Company operates through Drug Discovery, Drug Manufacturing and Genomics. It identifies and prioritizes therapeutic targets for drug discovery, epigenetic-related technologies and tools.

Feds: Morning-after pill appeal officially on hold The Obama...

This undated file photo provided by Barr Pharmaceuticals Inc., shows a package of Plan B One-Step, an emergency contraceptive.

Simcere Ties Up with Bristol-Myers - Analyst Blog

Simcere Pharmaceutical Group recently announced that it has entered into a strategic agreement with Bristol-Myers Squibb Company .

Label Expansion for Astellas Drug - Analyst Blog

Astellas Pharma Inc. recently announced the approval of Prograf in Japan for an additional indication.

Drugmakers Opened to - Pay for Delay' Suits in High Court Ruling

Drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs.

Supreme Court generics decision hits Actavis

A Supreme Court ruling issued Monday that works against generic-drug maker Actavis Inc. took a bite out of the company's shares in the minutes after it was issued, but others in the company's peer group didn't seem to be affected much by the decision.

U.S. top court says FTC can sue over deals that delay generic drug sales

The U.S. Supreme Court ruled on Monday regulators can challenge deals between brand-name drug companies and generic rivals that delay cheaper medicines from going on sale, which regulators say increase costs to consumers by billions of dollars.

High Court Sides With Regulators In Drug Patent Case

The Supreme Court sided with government regulators in an important case involving the pharmaceutical industry and patent law.

Firm hopes end to fake drugs is on Horizon

AN IRISH engineering company is leading the fight against counterfeit medicines, working with the pharmaceutical industry at home and abroad to implement sophisticated systems to guarantee drugs are genuine.

"Cardinal Health, Inc. (CAH) - Financial and Strategic SWOT Analysis...

The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.

Creative destruction

As the world of big drug companies streamlines operations by shrinking research-and-development staffs and outsourcing tasks amid patent losses on key medicines, the benefit is two-fold for specialty firms contracted to take on the work.

Sanofi head sees cures for what ails Canada's pharma sector

'You can't say research and innovation are your absolute priorities and then not protect ideas,' says Christopher Viehbacher, CEO of pharma giant Sanofi.

Are you horny, older women? There'll be a pill for that

I have a few questions for all you women out there. Be honest. Is your libido a bit less lively than it used to be? Are there times when you'd rather watch reruns of Mad Men than have an intimate encounter with your husband? When engaged in foreplay, do you ever think about the grocery list? When you read surveys claiming that average married ... (more)

Now Available: Barr Laboratories, Inc. - Mergers & Acquisitions...

Project Description: MarketLines' Barr Laboratories, Inc. Mergers & Acquisitions , Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions , divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Barr Laboratories, Inc.

Big Pharma's Biggest Opportunity

Emerging markets have heated up for every industry, but the world's biggest pharmaceutical players have approached the challenges of capturing these promising markets in unique ways.

Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival...

Bristol-Myers Squibb Company and AbbVie today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with previously-treated multiple myeloma that evaluated two doses of the investigational monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Mylan, Inc....

Growing Stock Report expands its NASDAQ Gainers Watch List adding ACADIA Pharmaceuticals Inc. and Mylan, Inc. .

Patheon To Host Complimentary Seminar On "Formulation, Funding and...

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced that it will be hosting a complimentary seminar on "Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success".

New Report Examines Efforts To Reduce The Impact Of Generic Competition For Popular Drug Lipitor

AARP's Public Policy Institute have released a new Rx Price Watch report examining efforts by Pfizer to reduce the impact of generic competition for the popular anti-cholesterol drug Lipitor.

Pfizer reaches $2.15 billion settlement in patent infringement battle

Pfizer Inc. reached a $2.15 billion settlement with Teva Pharmaceutical Industries and Sun Pharmaceutical Industries in a nearly 10-year patent infringement legal battle.

HFMA Survey Results Show Shifting Hospital-Physician Dynamics

Today's hospitals consider physician relationships critical to their success in an accountable care environment - whether through direct employment or affiliation with independent community physicians.

Fontenot v. Watson Pharmaceuticals, Inc.

After plaintiffs-appellees' case was removed from state court on the basis of diversity jurisdiction, the district court allowed the joinder of several non-diverse defendants and remanded the case.

Cardinal Health Given "Outperform" Rating at Credit Suisse

's stock had its "outperform" rating restated by investment analysts at Credit Suisse in a note issued to investors on Thursday, AnalystRatings.Net reports.

Plan B One-Step approved without restriction

In a huge win for women and choice, Plan B One-Step emergency contraception has been federally approved for over the counter sales without age restriction or need for a prescription.

Pharma Majors: 2 To Buy, 1 To Avoid And 1 To Sell

With the health care reform legislation expected to provide coverage for approximately 32 million previously Americans starting in 2014, the pharmaceutical industry should derive benefit from the new law taking effect - even accounting for the rising costs these companies might face because of this legislation.

Decelerating change in the pharmaceutical industry

Medical progress will have come to a complete halt by the year 2329. I reach this anti-Kurzweilian conclusion from a 2012 paper - Diagnosing the decline in pharmaceutical R&D efficiency - which demonstrates that, far from showing an accelerating rate of innovation, the pharmaceutical industry has for the last 60 years been seeing exponentially ... (more)

Oasmia Appoints New Vice President Communications

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Mikael has an extensive experience of communications from the international pharmaceutical industry, AstraZeneca and Biovitrum among others, and from investment companies such as Nordic Capital.

Cardinal Poised to Take Flight

The drug distributor's stock has lagged peers and the broader market but should outperform thanks to strong cash flow and rising margins.

Bayer AG Rating Reiterated by BNP Paribas

's stock had its "outperform" rating reaffirmed by stock analysts at BNP Paribas in a report issued on Wednesday, StockRatingsNetwork.com reports.

New Report Examines Efforts to Reduce the Impact of Generic Competition for Popular Drug Lipitor

The report breaks down the unusually aggressive strategy reportedly undertaken by Lipitor's manufacturer before and after the drug's patent expired and discusses how the effort could become a model for other brand name drug manufacturers facing generic competition, ultimately increasing costs for consumers and publicly-funded programs like Medicare ... (more)

Takeda Pharmaceutical Co. Ltd. and Sea Lane Biotechnologies, LLC Sign ...

Takeda Pharmaceutical Co. Ltd. and Sea Lane Biotechnologies, LLC Sign Licensing Agreement for Use of ConCIRT Libraries and Technology Staying up-to-date has never been simpler.

Pfizer, Takeda settle Protonix patent case with generic drugmakers for $2.15 billion

Pfizer says it has reached a $2.15 billion settlement with a couple of generic drugmakers over sales of their versions of the heartburn drug Protonix.

Fighting Corruption in the Pharmaceutical Industry With a Water Pistol

The NYT ran a column that discussed the massive corruption in the pharmaceutical industry and using a water pistol to rein it in.

Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Dr. Jeremy M. Levin, President & CEO, will present on Thursday, June 13, 2013. Live over the Internet - log on to the Web at the address above and register for the event .

McKesson Corporation Presents at Goldman Sachs 34th Annual Global...

All right, good morning, everyone, and welcome to the McKesson session. I'm Bob Jones, I cover the health care supply chain and technology sector at Goldman Sachs.

Feds: Morning-after pill appeal officially on hold

This undated file photo provided by Barr Pharmaceuticals Inc., shows a package of Plan B One-Step, an emergency contraceptive.

GDS International Leads the Way for the Pharmaceutical Industry at...

On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton Mirasierra Hotel & Spa, This year NGP DD 30 has elected 30 of the most well-respected decision makers from the pharmaceutical sector to meet, network, and assess the rapidly evolving industry in ... (more)

MedicPen AB and M2M DataSmart Collaborate for Expansion of Healthcare ...

SAN DIEGO, CA and HALMSTAD, SWEDEN, Jun 11, 2013 -- M2M DataSmart and MedicPen AB today announced a partnership that allows for medication delivery and tracking solutions to operate over secure cellular based technology for the emerging healthcare industry.

miRagen Therapeutics Adds Biotech and Pharmaceutical Industry Veterans to Senior Leadership Team

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! miRagen Therapeutics, Inc., a biopharmaceutical company discovering and developing innovative microRNA -targeting therapeutics, today announced the appointments of Christopher J. Morl, M.B.A., B.Sc.

Teva Pharmaceutical Industries Ltd Upgraded by TheStreet to Buy

The analysts wrote, "Teva Pharmaceutical Industries has been upgraded by TheStreet Ratings from hold to buy.

Hurley Consulting Associates Ltd. Announces Appointment of John C....

Dr. Talian is responsible for developing regulatory strategies, providing regulatory analyses, managing regulatory interactions with the FDA, and preparing dossiers for global submission to health authorities.

Women hail feds' NY contraceptive ruling stance

This undated file photo provided by Barr Pharmaceuticals Inc., shows a package of Plan B One-Step, an emergency contraceptive.

Feds tell NY judge they'll comply with order letting girls of any age buy morning-after pill

This undated file photo provided by Barr Pharmaceuticals Inc., shows a package of Plan B One-Step, an emergency contraceptive.

Morning-After Pill to Be Sold to All Ages, U.S. Says

The U.S. government told a federal judge it would make a branded version of the morning-after pill available to all women over-the-counter without age restrictions.

CIO Profiles: Randall Spratt Of McKesson

Career accomplishment I'm most proud of: Establishing an effective McKesson-wide governance process that covers all shared services at the enterprise level.